# Oxford Nanoimaging

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oxford-nanoimaging

- Industry: Medical Devices & Equipment
- Headquarters: Oxford, UK
- Website: www.oni.bio
- Total disclosed funding: $111M
- Latest round: Series B (Dec 21, 2021)
- Investors on record: 10

## About

Founded in 2016, and based in Oxford, UK, Oxford Nanoimaging Ltd, trading under the name ONI, operates as a biotechnology company that offers super-resolution microscopy solutions for its users. The company was founded by its CEO Bo Jing. In January 2022, Oxford Nanoimaging Ltd raised USD 75 million in series B funding co-led by new investor ARCH Venture Partners and returning investor Casdin Capital.

ONI offers a desktop super-resolution microscopy with 20-nanometer resolution called Nanoimager that can access high-resolution nanoimaging techniques like dSTORM and PALM, as well as smFRET, single-particle tracking, and confocal microscopy. The Nanoimager is used in conjunction with NimOS, the company's microscope software that analyses data from the Nanoimager and renders super-resolution images in near real-time for users.

The company plans to use the funding to expand its management team and board of directors with the addition of several industry veterans.

## Funding rounds

- Series B, Dec 21, 2021, $76M — ARCH Venture Partners, ARTIS Ventures, Casdin Capital, Vertical Venture Partners, Axon Ventures, Oxford Sciences Enterprises, Section 32, True Capital Partners, LLC
- Series A, Aug 28, 2020, $5.3M — Casdin Capital
- Series A, May 16, 2018, $25M — Casdin Capital, Oxford Sciences Enterprises, Puhua Capital, GT Healthcare Capital Partners
- Seed, Apr 10, 2017, $3.7M — Oxford Sciences Enterprises, GT Healthcare Capital Partners
- Seed, Apr 30, 2016, $1.8M — Oxford Sciences Enterprises

## Investors

- Oxford Sciences Enterprises (https://capitalatlas.ai/funds/oxford-sciences-enterprises) — Seed, Series A, Series B
- GT Healthcare Capital Partners (https://capitalatlas.ai/funds/gt-healthcare-capital-partners) — Seed, Series A
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A, Series B
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Series A
- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series B
- ARTIS Ventures (https://capitalatlas.ai/funds/artis-ventures) — Series B
- Vertical Venture Partners (https://capitalatlas.ai/funds/vertical-venture-partners) — Series B
- Axon Ventures — Series B
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series B
- True Capital Partners, LLC — Series B